Eusol Biotech Co (ROCO:6652) Total Assets : NT$377.91 Mil (As of Dec. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Eusol Biotech Co Total Assets?

Eusol Biotech Co's Total Assets for the quarter that ended in Dec. 2024 was NT$377.91 Mil.

During the past 12 months, Eusol Biotech Co's average Total Assets Growth Rate was 9.00% per year. During the past 3 years, the average Total Assets Growth Rate was -42.40% per year. During the past 5 years, the average Total Assets Growth Rate was -38.20% per year.

During the past 10 years, Eusol Biotech Co's highest 3-Year average Total Assets Growth Rate was 8.00%. The lowest was -47.00%. And the median was -13.80%.

Total Assets is connected with ROA %. Eusol Biotech Co's annualized ROA % for the quarter that ended in Dec. 2024 was -7.66%. Total Assets is also linked to Revenue through Asset Turnover. Eusol Biotech Co's Asset Turnover for the quarter that ended in Dec. 2024 was 0.00.

Eusol Biotech Co Total Assets Historical Data

The historical data trend for Eusol Biotech Co's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eusol Biotech Co Total Assets Chart

Eusol Biotech Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Assets

Get a 7-Day Free Trial

281.11

454.91

440.81

410.26

377.91

Eusol Biotech Co Semi-Annual Data
	Dec15	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Total Assets	Get a 7-Day Free Trial													440.81	428.66	410.26	395.93	377.91

Eusol Biotech Co Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Eusol Biotech Co's Total Assets for the fiscal year that ended in Dec. 2024 is calculated as

Total Assets	=	Total Equity (A: Dec. 2024 )	+	Total Liabilities (A: Dec. 2024 )
	=	370.434	+	7.48
	=	377.91

Eusol Biotech Co's Total Assets for the quarter that ended in Dec. 2024 is calculated as

Total Assets	=	Total Equity (Q: Dec. 2024 )	+	Total Liabilities (Q: Dec. 2024 )
	=	370.434	+	7.48
	=	377.91

Eusol Biotech Co (ROCO:6652) Total Assets Explanation

Total Assets is connected with ROA %.

Eusol Biotech Co's annualized ROA % for the quarter that ended in Dec. 2024 is

ROA %	=	Net Income (Q: Dec. 2024 )	/	( (Total Assets (Q: Jun. 2024 )	+	Total Assets (Q: Dec. 2024 ))	/ count )
	=	-29.644	/	( (395.925	+	377.914)	/ 2 )
	=	-29.644	/	386.9195
	=	-7.66 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Eusol Biotech Co's Asset Turnover for the quarter that ended in Dec. 2024 is

	Asset Turnover
=	Revenue (Q: Dec. 2024 )	/	( (Total Assets (Q: Jun. 2024 )	+	Total Assets (Q: Dec. 2024 ))	/ count )
=	0	/	( (395.925	+	377.914)	/ 2 )
=	0	/	386.9195
=	0.00

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Eusol Biotech Co Total Assets Related Terms

Thank you for viewing the detailed overview of Eusol Biotech Co's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Eusol Biotech Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Eusol Biotech Co Ltd (ROCO:6652) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.135, Section 3, Minsheng East Road, 6th Floor, Songshan District, Taipei, TWN, 10546

Website

https://www.eusol.com.tw

Eusol Biotech Co Ltd is a Taiwan based company that invests in developing new drugs to fulfill unmet medical needs. Its pipeline products include ES135, a recombinant human acidic fibroblast growth factor (rhFGF1) with 135 amino acids; and SM-1, a 3-in-1 capsule containing 3 commercial drugs with the sedative effect.

Eusol Biotech Co Headlines

No Headlines